An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155

Summary

This protocol is open to subjects previously enrolled in and who had completed a Phase I or Phase II study administering YM155. Subjects who are receiving benefit from treatment with YM155 are eligible after completing the previous study.

Timeline

Start

2006-02

Primary completion

2011-03

Completion

2012-08

Drugs

Indications